Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Radiation Oncology
•
Radiation Biology
•
General Radiation Oncology
Do patients with homocystinuria have an increase risk of radiation toxicity?
Would one expect a higher risk of rad effects?
Related Questions
Can patients receive adjuvant radiation therapy after keloid excision without primary closure, or would radiation impede healing by secondary intention?
Is it safe to administer Lu 177 therapies in patients with epidural disease in the spinal canal?
Do you routinely offer spine SBRT for vertebral metastases regardless of overall patient disease burden or response?
What is your approach to management of radiation-induced bullous pemphigoid?
When do you consider elective pelvic nodal irradiation for unfavorable intermediate risk prostate cancer?
For patients with peritoneal carcinomatosis and minimal response to neoadjuvant chemotherapy, is there a benefit to palliative cytoreductive surgery followed by whole abdominal radiotherapy?
Is there a benefit in proactively referring patients treated with pelvic radiation to see pelvic rehabilitation in the absence of any symptoms?
Would you re-irradiate a spleen with increasing splenomegaly for a patient with myelofibrosis?
How do you manage the thickened secretions secondary to xerostomia during head and neck radiation?
How do you manage intradural - extramedullary metastases of the spinal cord from non-CNS malignancies?
